The mission of the Cancer Therapeutics & Host Response Research Program is to advance understanding of interactions between tumor cells, immune cells, and microbiota that mediate tumor development, progression and host responses, and to develop therapeutics that capitalize on these mechanisms and interactions.
132 members from eight colleges and 32 departments
- Develop novel immunotherapies for refractory cancer
- Elucidate microbiome function in cancer development and therapeutics
- Identify and validate targeted therapeutics engaging key cancer pathways with small molecules and test new therapies in clinical trials